The global bronchitis treatment market size was exhibited at USD 6.13 billion in 2022 and is projected to hit around USD 10.19 billion by 2032, growing at a CAGR of 5.21% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The condition of bronchitis has been divided under two heads which are chronic and acute. The symptoms which are associated with the condition of bronchitis include dyspnea, secretion, whistling sound while breathing, pain in the chest and cough with mucus. This is a very common respiratory tract disease that has been observed in people belonging to developing as well as developed countries.
Various environmental factors are responsible for causing the condition of bronchitis which will emerge as the major driving force for the growth of the bronchitis treatment market during the forecast period. Various factors that tend to cause the condition of bronchitis include chronic tendency to acquire flu and cold, bacterial infection and bad habits such as smoking. Smoking cigarettes has proved to be a major causative factor for bronchitis and hence is considered as acquired bronchitis. The market is expected to experience a tremendous boost during the forecast period because of these factors.
Various causative factors that lead to the condition of bronchitis include smoking of cigarettes which proves to be the most common cause of this disease. Bacterial infections that are caused inside the respiratory tract lead to the problem of bronchitis which is foreseen to support the growth of the market during the forecast period. As a result of increasing environmental pollution, the number of patients suffering from bronchitis is increasing rapidly. Patients who are suffering from acute bronchitis mainly acquire the disease as a result of sudden changes in environment and exposure to dust. Patients who suffered from chronic bronchitis usually have a back history of chronic cigarette smoking and other types of respiratory diseases. The breathing capacity of the lungs is affected to a great extent in patients who are suffering from bronchitis. The defense system of the lungs against infections is hampered for a considerable period of time which results in bronchitis. The number of patients suffering from chronic obstructive pulmonary disorder has also rapidly increased, which is expected to support the growth of the market in the long run.
|Market Size in 2023
|USD 6.45 Billion
|Market Size by 2032
|USD 10.19 Billion
|Growth Rate from 2023 to 2032
|CAGR of 5.21%
|2023 to 2032
|By Type, By Treatment, By Drug Class, and By Distribution Channel
|North America, Europe, Asia-Pacific, Latin America and Middle East & Africa
Key Market Drivers
Key Market Restraints
High cost of drugs - The cost of the drugs that are utilized for the treatment of bronchitis is high which hampers the growth of the market to a great extent. The people belonging to developing and underdeveloped nations cannot afford such advanced medicines for treatment.
Strict rules and regulations - The stringent rules and regulations that are associated with the introduction of drugs into the market emerge as a major restraining factor.
Key Market Opportunities
External causative factors - Various external causative factors such as dust, pollution, fumes, and chemicals lead to bronchitis. The chemical pollutants behave as a primary causative factor for bronchitis which in turn emerges as a major opportunity for the growth of the bronchitis treatment market.
Increasing demand for efficient treatment - As a result of increasing awareness among people regarding the various treatment options available in the market, people wish to opt for efficient treatment solutions that provide maximum results with minimum side effects on the body.
Key Market Challenges
Strict government guidelines - The guidelines that need to be followed for the release of medicines and drugs into the market emerges as a major challenge for the growth of the bronchitis treatment market. the cost that has to be paid for the approval of the drugs is considerably high which hampers the growth of the market to a great extent.
Based on type, the segment of chronic bronchitis has emerged as the largest segment due to the huge number of cases that are found in society. an underlying health condition proves to be a major causative factor for chronic bronchitis. A productive cough is seen in the patient for a considerable period which lasts for more than three months. Chronic bronchitis is a common ailment among the people belonging to the geriatric population. The people suffering with chronic bronchitis usually suffer with an underlying lung pathology or with a past history of respiratory disease. As a result of faulty lifestyle practice the risk of chronic bronchitis increases among the people belonging to the geriatric population.
The segment of acute bronchitis is also gradually growing because of the extreme environmental conditions that are being experienced as a result of global warming and increasing pollution. As a result of increasing awareness among the people regarding the available treatment options for bronchitis the market is experiencing a tremendous response.
Based on drug class, the antibiotic segment has emerged as the largest segment as a result of its rampant utilization among most of the physicians and practitioners all over the world in case of any infection. Antibiotics emerge as the most common drug that are sold over the counter for almost all types of disorders. The effect of the antibiotics on any infection helps to cure or improve the symptoms better presented by the patient to the doctor. The segment of anti-inflammatory drugs has also proved to be a fast-growing segment because of its increasing demand among most of consumers.
The segment of bronchodilators emerges as the next largest segment as these drugs help to provide immediate relief to the patients by helping them to clear air passages and hence enables them to breathe properly. As a result of constant research and development that are carried out by the key market players new medicines and drugs are being introduced into the market for treating acute and chronic bronchitis. A considerable boost has been provided by the segment of bronchodilators during the course of the pandemic as these medicines helped to provide quick relief to the patients during the moments of distress.
Based on the distribution channel, the segment of hospital pharmacies has emerged as the largest segment as a huge number of patients are attended in the premises of the hospital. People usually prefer to purchase medicines from the hospital pharmacies themselves and then get them checked by the physician to avoid any future confusion. Hospital pharmacies have a continuous demand and supply chain that runs based on the prescriptions that are made by the physician in the hospital.
The segment of retail pharmacies has also gained momentum in recent times because of the OTC medicines that are distributed to patients. Along with the increasing awareness among the people regarding the various actions of medicines and drugs, people prefer to purchase the medicines from retail pharmacies and hence opt for self-medication.
The increasing trend of online shopping has boosted the segment of online pharmacies to a great extent which is expected to grow further during the forecast period. A huge number of patients all over the world prefer to purchase their medicines from online pharmacies because of the heavy discounts that are provided by these online platforms. A huge number of patients all over the world belong to the general population who prefer to get delivery services within their own premises as they do not have suitable transportation facilities.
During the course of the pandemic, the platform of online pharmacies gained tremendous momentum because of the various restrictions that were imposed by governments all over the world.
Based on geography, the region of North America has emerged as the largest global market for bronchitis treatment because of the huge number of patients that reside in this part of the world. The increasing prevalence of respiratory diseases among the people in this region has boosted the market to a great extent. A huge number of patients suffering with bronchitis are found in the region of North America. The factor of health awareness among people has also boosted the market for bronchitis treatment to a great extent. The infrastructure that is provided for healthcare services by the government to the people emerged as the major driving force for the growth of the bronchitis treatment market.
The second largest market in the bronchitis treatment sector is held by the region of Europe as a result of the advanced healthcare facilities that are provided to the people by the government. The facilities that are provided by the health insurance companies encourage people to opt for advanced treatment options which in turn supports the growth of the bronchitis treatment market to a great extent. The increasing number of people suffering with chronic diseases in the region of Europe has emerged as a major reason for the growth of the bronchitis treatment market. The active participation of the European Commission In the healthcare sector has boosted the market to a great extent. And enormous potential has been presented by the region of Asia Pacific which is expected to grow further during the forecast period.
Segments Covered in the Report
By Drug Class
By Distribution Channel
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client